Skip to main content

Peer Review reports

From: ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization

Original Submission
19 Mar 2023 Submitted Original manuscript
11 Apr 2023 Reviewed Reviewer Report
13 Apr 2023 Reviewed Reviewer Report
20 Apr 2023 Reviewed Reviewer Report
25 Apr 2023 Reviewed Reviewer Report
1 Jul 2023 Author responded Author comments - Xiaolin Lu
Resubmission - Version 2
1 Jul 2023 Submitted Manuscript version 2
4 Jul 2023 Reviewed Reviewer Report
4 Jul 2023 Reviewed Reviewer Report
4 Jul 2023 Reviewed Reviewer Report
11 Jul 2023 Reviewed Reviewer Report
6 Aug 2023 Author responded Author comments - Xiaolin Lu
Resubmission - Version 3
6 Aug 2023 Submitted Manuscript version 3
Publishing
4 Sep 2023 Editorially accepted
25 Sep 2023 Article published 10.1186/s12916-023-03066-4

You can find further information about peer review here.

Back to article page